Takeo Isozaki

Elevated levels of soluble fractalkine in active systemic lupus erythematosus: Potential involvement in neuropsychiatric manifestations

Nobuyuki Yajima, Takeo Isozaki, Tsuyoshi Odai et al. · Arthritis & Rheumatism · 2005 · 95 citations

Life Sciences, Clinical Sciences, Immunology +17

Evidence That CXCL16 Is a Potent Mediator of Angiogenesis and Is Involved in Endothelial Progenitor Cell Chemotaxis: Studies in Mice With K/BxN Serum–Induced Arthritis

Takeo Isozaki, Ali S. Arbab, Christian S. Haas et al. · Arthritis & Rheumatism · 2013 · 81 citations · Full text

Medicine, Immunology, Pathobiology +11

Increased serum levels of soluble fractalkine (CX₃CL1) correlate with disease activity in rheumatoid vasculitis

Mizuho Matsunawa, Takeo Isozaki, Tsuyoshi Odai et al. · Arthritis & Rheumatism · 2006 · 75 citations

Life Sciences, Immunology, Internal Medicine +15

ADAM‐10 is overexpressed in rheumatoid arthritis synovial tissue and mediates angiogenesis

Takeo Isozaki, Bradley J. Rabquer, Jeffrey H. Ruth et al. · Arthritis & Rheumatism · 2012 · 61 citations · Full text

Life Sciences, Molecular Biology, Pathobiology +16

Citrullination of Epithelial Neutrophil–Activating Peptide 78/CXCL5 Results in Conversion From a Non–Monocyte‐Recruiting Chemokine to a Monocyte‐Recruiting Chemokine

Ken Yoshida, Olexandr Korchynskyi, Paul P. Tak et al. · Arthritis & Rheumatology · 2014 · 60 citations · Full text

Medicine, Immunology, Internal Medicine +17